Document:

Exhibit 10.3

 

PRIVATE PLACEMENT WARRANTS PURCHASE
AGREEMENT

 

THIS PRIVATE PLACEMENT
WARRANTS PURCHASE AGREEMENT, dated as of May 26, 2020 (as it may from time to time be amended and including all exhibits referenced
herein, this “Agreement”), is entered into by and between Foley Trasimene Acquisition Corp., a Delaware corporation
(the “Company”), Bilcar FT, LP, a Delaware limited partnership (the “Bilcar Sponsor”), and
Trasimene Capital FT, LP, a Delaware limited partnership (the “Trasimene Sponsor”, and together with the Bilcar
Sponsor, the “Purchasers”).

 

WHEREAS, the Company
intends to consummate an initial public offering of the Company’s units (the “Public Offering”), each
unit consisting of one share of the Company’s Class A common stock, par value $0.0001 per share (each, a “Class
A share”), and one-third of one redeemable warrant;

 

WHEREAS, each whole
warrant entitles the holder to purchase one Class A share at an exercise price of $11.50 per share, as set forth in the Company’s
Registration Statement on Form S-1, filed with the U.S. Securities and Exchange Commission (the “SEC”), File
Number 333-238135 (the “Registration Statement”), under the Securities Act of 1933, as amended (the “Securities
Act”); and

 

WHEREAS, the
Purchasers have agreed to purchase an aggregate of 13,333,333 warrants (or 15,133,333 warrants in the aggregate if the
over-allotment option in connection with the Public Offering is exercised in full) (the “Private Placement
Warrants”), each Private Placement Warrant entitling the holder to purchase one Class A share at an exercise price
of $11.50 per Class A share, at a price of $1.50 per warrant. Out of the total amount of Private Placement Warrants, the
Bilcar Sponsor has agreed to purchase an aggregate of 4,000,000 Private Placement Warrants (or 4,540,000 Private Placement
Warrants in the aggregate if the over- allotment option in connection with the Public Offering is exercised in full), and the
Trasimene Sponsor has agreed to purchase an aggregate of 9,333,333 Private Placement Warrants (or 10,593,333 Private Placement
Warrants in the aggregate if the over- allotment option in connection with the Public Offering is exercised in full).

 

NOW THEREFORE, in consideration
of the mutual promises contained in this Agreement and other good and valuable consideration, the receipt and sufficiency of which
are hereby acknowledged, the parties to this Agreement hereby, intending legally to be bound, agree as follows:

 

AGREEMENT

 

Section
1.  Authorization, Purchase and Sale; Terms of the Private Placement Warrants.

 

A.                 
Authorization of the Private Placement Warrants. The Company has duly authorized the issuance and sale of the Private
Placement Warrants to the Purchasers.

 

B.                 
Purchase and Sale of the Private Placement Warrants.

 

(i)                 
On the date of the consummation of the Public Offering or on such earlier time and date as may be mutually agreed by the
Purchasers and the Company (the “IPO Closing Date”), the Company shall issue and sell to the Purchasers, and
the Purchasers shall purchase from the Company, 13,333,333 Private Placement Warrants at a price of $1.50 per warrant for an aggregate
purchase price of $19,999,999.50 (the “Purchase Price”). The Purchasers shall pay the Purchase Price by wire transfer
of immediately available funds to the Company, to the trust account, at a financial institution to be chosen by the Company, maintained
by Continental Stock Transfer & Trust Company, acting as trustee, in accordance with the Company’s wiring instructions
(the “Trust Account”), at least one (1) business day prior to the IPO Closing Date. On the IPO Closing Date,
upon the payment by the Purchasers of the Purchase Price, by wire transfer of immediately available funds to the Company, the Company,
at its option, shall deliver a certificate evidencing the Private Placement Warrants purchased by each of the Purchasers on such
date duly registered in each of the Purchaser’s names to each of the Purchasers or effect such delivery in book-entry form.

 

(ii)                On
the date of any closing of the over-allotment option, if any, in connection with the Public Offering or on such earlier time
and date as may be mutually agreed by the Purchasers and the Company (each such date, an “Over-allotment Closing
Date,” and each Over-allotment Closing Date (if any) and the IPO Closing Date, being sometimes referred to herein
as a “Closing Date”), the Company shall issue and sell to the Purchasers, and the Purchasers shall
purchase from the Company, up to an aggregate of 1,500,000 Private Placement Warrants, in the same proportion as the amount
of the option that is then so exercised, at a price of $1.50 per warrant for an aggregate purchase price of up to $2,250,000
(if the over-allotment option in connection with the Public Offering is exercised in full) (the “Over-allotment
Purchase Price”). Each of the Purchasers shall pay the Over-allotment Purchase Price in accordance with the
Company’s wire instruction by wire transfer of immediately available funds to the Trust Account at least one (1)
business day prior to such Over-allotment Closing Date. On the Over-allotment Closing Date, following the payment by the
Purchaser of the Over-allotment Purchase Price by wire transfer of immediately available funds to the Company, the Company,
at its option, shall deliver a certificate evidencing the Private Placement Warrants purchased by the Purchaser on such date
duly registered in the Purchaser’s name to the Purchaser, or effect such delivery in book-entry form.

 

    1

     

    

 

C.                 
Terms of the Private Placement Warrants.

 

(i)                 
Each Private Placement Warrant shall have the terms set forth in a Warrant Agreement to be entered into by the Company and
a warrant agent on the IPO Closing Date, in connection with the Public Offering (the “Warrant Agreement”).

 

(ii)               
At the time of, or prior to, the closing of the Public Offering, the Company and the Purchaser shall enter into a registration
rights agreement (the “Registration Rights Agreement”) pursuant to which the Company will grant certain registration
rights to the Purchaser relating to the Private Placement Warrants and the Class A shares underlying the Private Placement Warrants.

 

Section
2. Representations and Warranties of the Company. As a material inducement to the Purchaser to enter into this
Agreement and purchase the Private Placement Warrants, the Company hereby represents and warrants to the Purchaser (which representations
and warranties shall survive each Closing Date) that:

 

A.                 
Incorporation and Corporate Power. The Company is a corporation duly incorporated, validly existing and in good standing
under the laws of the State of Delaware and is qualified to do business in every jurisdiction in which the failure to so qualify
would reasonably be expected to have a material adverse effect on the financial condition, operating results or assets of the Company.
The Company possesses all requisite corporate power and authority necessary to carry out the transactions contemplated by this
Agreement and the Warrant Agreement.

 

B.                 
Authorization; No Breach.

 

(i)                 
The execution, delivery and performance of this Agreement and the Private Placement Warrants have been duly authorized by
the Company as of the IPO Closing Date. This Agreement constitutes the valid and binding obligation of the Company, enforceable
in accordance with its terms, subject to bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium and other laws
of general applicability relating to or affecting creditors’ rights and to general equitable principles (whether considered
in a proceeding in equity or law). Upon issuance in accordance with, and payment pursuant to, the terms of the Warrant Agreement
and this Agreement, the Private Placement Warrants will constitute valid and binding obligations of the Company, enforceable in
accordance with their terms as of each Closing Date.

 

(ii)               
The execution and delivery by the Company of this Agreement and the Private Placement Warrants, the issuance and sale of
the Private Placement Warrants, the issuance of the Class A shares upon exercise of the Private Placement Warrants and the fulfillment,
of and compliance with, the respective terms hereof and thereof by the Company, do not and will not as of each Closing Date (a)
conflict with or result in a breach of the terms, conditions or provisions of, (b) constitute a default under, (c) result in the
creation of any lien, security interest, charge or encumbrance upon the Company’s capital stock or assets under, (d) result
in a violation of, or (e) require any authorization, consent, approval, exemption or other action by or notice or declaration to,
or filing with, any court or administrative or governmental body or agency pursuant to, the second amended and restated certificate
of incorporation of the Company or the amended and restated bylaws of the Company (in effect on the date hereof or as may be amended
prior to completion of the Public Offering), or any material law, statute, rule or regulation to which the Company is subject,
or any agreement, order, judgment or decree to which the Company is subject, except for any filings required after the date hereof
under federal or state securities laws.

 

C.                 
Title to Securities. Upon issuance in accordance with, and payment pursuant to, the terms hereof and the Warrant
Agreement, the Class A shares issuable upon exercise of the Private Placement Warrants will be duly and validly issued, fully paid
and nonassessable. Upon issuance in accordance with, and payment pursuant to, the terms hereof and the Warrant Agreement, the Purchaser
will have good title to the Private Placement Warrants and the Class A shares issuable upon exercise of such Private Placement
Warrants, free and clear of all liens, claims and encumbrances of any kind, other than (i) transfer restrictions hereunder and
under the other agreements contemplated hereby, (ii) transfer restrictions under federal and state securities laws, and (iii) liens,
claims or encumbrances imposed due to the actions of the Purchaser.

 

D.                 
Governmental Consents. No permit, consent, approval or authorization of, or declaration to or filing with, any governmental
authority is required in connection with the execution, delivery and performance by the Company of this Agreement or the consummation
by the Company of any other transactions contemplated hereby.

 

    2

     

    

 

E.                  
Regulation D Qualification. Neither the Company nor, to its actual knowledge, any of its affiliates, members, officers,
directors or beneficial shareholders of 20% or more of its outstanding securities, has experienced a disqualifying event as enumerated
pursuant to Rule 506(d) of Regulation D under the Securities Act.

 

Section
3. Representations and Warranties of the Purchaser. As a material inducement to the Company to enter into this
Agreement and issue and sell the Private Placement Warrants to the Purchaser, the Purchaser hereby represents and warrants to the
Company (which representations and warranties shall survive each Closing Date) that:

 

A.                 
Organization and Requisite Authority. The Purchaser possesses all requisite power and authority necessary to carry
out the transactions contemplated by this Agreement.

 

B.                 
Authorization; No Breach.

 

(i)                 
This Agreement constitutes a valid and binding obligation of the Purchaser, enforceable in accordance with its terms, subject
to bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium and other laws of general applicability relating to
or affecting creditors’ rights and to general equitable principles (whether considered in a proceeding in equity or law).

 

(ii)               
The execution and delivery by the Purchaser of this Agreement and the fulfillment of and compliance with the terms hereof
by the Purchaser does not and shall not as of each Closing Date (a) conflict with or result in a breach by the Purchaser of the
terms, conditions or provisions of, (b) constitute a default under, (c) result in the creation of any lien, security interest,
charge or encumbrance upon the Purchaser’s equity or assets under, (d) result in a violation of, or (e) require any authorization,
consent, approval, exemption or other action by or notice or declaration to, or filing with, any court or administrative or governmental
body or agency pursuant to the Purchaser’s organizational documents in effect on the date hereof or as may be amended prior
to completion of the contemplated Public Offering, or any material law, statute, rule or regulation to which the Purchaser is subject,
or any agreement, instrument, order, judgment or decree to which the Purchaser is subject, except for any filings required after
the date hereof under federal or state securities laws.

 

C.                 
Investment Representations.

 

(i)                 
The Purchaser is acquiring the Private Placement Warrants and, upon exercise of the Private Placement Warrants, the Class
A shares issuable upon such exercise (collectively, the “Securities”), for the Purchaser’s own account,
for investment purposes only and not with a view towards, or for resale in connection with, any public sale or distribution thereof.

 

(ii)               
The Purchaser is an “accredited investor” as such term is defined in Rule 501(a)(3) of Regulation D, and the
Purchaser has not experienced a disqualifying event as enumerated pursuant to Rule 506(d) of Regulation D under the Securities
Act.

 

(iii)             
The Purchaser understands that the Securities are being offered and will be sold to it in reliance on specific exemptions
from the registration requirements of the United States federal and state securities laws and that the Company is relying upon
the truth and accuracy of, and the Purchaser’s compliance with, the representations and warranties of the Purchaser set forth
herein in order to determine the availability of such exemptions and the eligibility of the Purchaser to acquire such Securities.

 

(iv)              
The Purchaser did not decide to enter into this Agreement as a result of any general solicitation or general advertising
within the meaning of Rule 502(c) of Regulation D under the Securities Act.

 

(v)               
The Purchaser has been furnished with all materials relating to the business, finances and operations of the Company and
materials relating to the offer and sale of the Securities which have been requested by the Purchaser. The Purchaser has been afforded
the opportunity to ask questions of the executive officers and directors of the Company. The Purchaser understands that its investment
in the Securities involves a high degree of risk and it has sought such accounting, legal and tax advice as it has considered necessary
to make an informed investment decision with respect to the acquisition of the Securities.

 

(vi)              
The Purchaser understands that no United States federal or state agency or any other government or governmental agency has
passed on or made any recommendation or endorsement of the Securities or the fairness or suitability of the investment in the Securities
by the Purchaser nor have such authorities passed upon or endorsed the merits of the offering of the Securities.

 

    3

     

    

 

(vii)            
The Purchaser understands that: (a) the Securities have not been and are not being registered under the Securities Act or
any state securities laws, and may not be offered for sale, sold, assigned or transferred unless (1) subsequently registered thereunder
or (2) sold in reliance on an exemption therefrom; and (b) except as specifically set forth in the Registration Rights Agreement,
neither the Company nor any other person is under any obligation to register the Securities under the Securities Act or any state
securities laws or to comply with the terms and conditions of any exemption thereunder. In this regard, the Purchaser understands
that the SEC has taken the position that promoters or affiliates of a blank check company and their transferees, both before and
after an initial Business Combination, are deemed to be “underwriters” under the Securities Act when reselling the
securities of a blank check company. Based on that position, Rule 144 adopted pursuant to the Securities Act would not be available
for resale transactions of the Securities despite technical compliance with the requirements of such Rule, and the Securities can
be resold only through a registered offering or in reliance upon another exemption from the registration requirements of the Securities
Act.

 

(viii)          
The Purchaser has such knowledge and experience in financial and business matters, knowledge of the high degree of risk
associated with investments in the securities of companies in the development stage such as the Company, is capable of evaluating
the merits and risks of an investment in the Securities and is able to bear the economic risk of an investment in the Securities
in the amount contemplated hereunder for an indefinite period of time. The Purchaser has adequate means of providing for its current
financial needs and contingencies and will have no current or anticipated future needs for liquidity which would be jeopardized
by the investment in the Securities. The Purchaser can afford a complete loss of its investments in the Securities.

 

(ix)              
The Purchaser understands that the Private Placement Warrants shall bear the legend substantially in the form set forth
in the Warrant Agreement.

 

Section
4. Conditions of the Purchaser’s Obligations. The obligations of the Purchaser to purchase and pay for
the Private Placement Warrants are subject to the fulfillment, on or before each Closing Date, of each of the following conditions:

 

A.                 
Representations and Warranties. The representations and warranties of the Company contained in Section 2 shall be
true and correct at and as of such Closing Date as though then made.

 

B.                 
Performance. The Company shall have performed and complied with all agreements, obligations and conditions contained
in this Agreement that are required to be performed or complied with by it on or before such Closing Date.

 

C.                 
No Injunction. No litigation, statute, rule, regulation, executive order, decree, ruling or injunction shall have
been enacted, entered, promulgated or endorsed by or in any court or governmental authority of competent jurisdiction or any self-regulatory
organization having authority over the matters contemplated hereby, which prohibits the consummation of any of the transactions
contemplated by this Agreement or the Warrant Agreement.

 

D.                 
Warrant Agreement and Registration Rights Agreement. The Company shall have entered into the Warrant Agreement, in
the form of Exhibit A hereto, and the Registration Rights Agreement, in the form of Exhibit B hereto, in each case
on terms satisfactory to the Purchaser.

 

Section
5. Conditions of the Company’s Obligations. The obligations of the Company to the Purchaser under this
Agreement are subject to the fulfillment, on or before each Closing Date, of each of the following conditions:

 

A.                 
Representations and Warranties. The representations and warranties of the Purchaser contained in Section 3 shall
be true and correct at and as of such Closing Date as though then made.

 

B.                 
Performance. The Purchaser shall have performed and complied with all agreements, obligations and conditions contained
in this Agreement that are required to be performed or complied with by the Purchaser on or before such Closing Date.

 

C.                 
Corporate Consents. The Company shall have obtained the consent of its Board of Directors authorizing the execution,
delivery and performance of this Agreement and the Warrant Agreement and the issuance and sale of the Private Placement Warrants
hereunder.

 

D.                 
No Injunction. No litigation, statute, rule, regulation, executive order, decree, ruling or injunction shall have
been enacted, entered, promulgated or endorsed by or in any court or governmental authority of competent jurisdiction or any self-regulatory
organization having authority over the matters contemplated hereby, which prohibits the consummation of any of the transactions
contemplated by this Agreement or the Warrant Agreement.

 

    4

     

    

 

E.                  
Warrant Agreement. The Company shall have entered into the Warrant Agreement with a warrant agent on terms satisfactory
to the Company.

 

Section
6. Termination. This Agreement may be terminated at any time after December 31, 2020 upon the election by either
the Company or the Purchaser upon written notice to the other party if the closing of the Public Offering does not occur prior
to such date.

 

Section
7. Survival of Representations and Warranties. All of the representations and warranties contained herein shall
survive each Closing Date.

 

Section
8. Definitions. Terms used but not otherwise defined in this Agreement shall have the meaning assigned to such
terms in the Registration Statement on Form S-1 the Company has filed with the SEC, under the Securities Act.

 

Section
9. Miscellaneous.

 

A.                 
Successors and Assigns. Except as otherwise expressly provided herein, all covenants and agreements contained in
this Agreement by or on behalf of any of the parties hereto shall bind and inure to the benefit of the respective successors of
the parties hereto whether so expressed or not. Notwithstanding the foregoing or anything to the contrary herein, the parties may
not assign this Agreement, other than assignments by the Purchaser to affiliates thereof.

 

B.                 
Severability. Whenever possible, each provision of this Agreement shall be interpreted in such manner as to be effective
and valid under applicable law, but if any provision of this Agreement is held to be prohibited by or invalid under applicable
law, such provision shall be ineffective only to the extent of such prohibition or invalidity, without invalidating the remainder
of this Agreement.

 

C.                 
Counterparts. This Agreement may be executed simultaneously in two or more counterparts, none of which need contain
the signatures of more than one party, but all such counterparts taken together shall constitute one and the same agreement.

 

D.                 
Descriptive Headings; Interpretation. The descriptive headings of this Agreement are inserted for convenience only
and do not constitute a substantive part of this Agreement. The use of the word “including” in this Agreement
shall be by way of example rather than by limitation.

 

E.                  
Governing Law. This Agreement shall be deemed to be a contract made under the laws of the State of New York and for
all purposes shall be construed in accordance with the internal laws of the State of New York, without giving effect to conflicts
of law principles that would result in the application of the laws of another jurisdiction.

 

F.                  
Amendments. This Agreement may not be amended, modified or waived as to any particular provision, except by a written
instrument executed by all parties hereto.

 

[Signature page follows]

 

    5

     

    

 

IN WITNESS WHEREOF,
the parties hereto have executed this Agreement to be effective as of the date first set forth above.

 

	 	COMPANY:
	 	 
	 	FOLEY TRASIMENE ACQUISITION CORP.
	 	
	 	By:	/s/ Michael L. Gravelle
	 	 	Name: Michael L .Gravelle
	 	 	Title:   General Counsel and Corporate Secretary
	 	 	 
	 	 PURCHASERS:
	 	 
	 	TRASIMENE CAPITAL FT, LP

                

	 	 
	 	By its General Partner,
	 	Trasimene Capital FT, LLC
	 	 
	 	By:	/s/ Michael L. Gravelle
	 	 	Name: Michael L .Gravelle
	 	 	Title:   General Counsel and Corporate Secretary
	 	 
	 	BILCAR FT, LP
	 	 
	 	

                By its General Partner, 
 Bilcar FT, LLC

	 	 
	 	By: Member
	 	 
	 	By:	/s/ Michael L. Gravelle
	 	 	Name: Michael L. Gravelle
	 	 	Title:   General Counsel and Corporate Secretary

 

[Signature Page
to Private Placement Warrants Purchase Agreement]

 

     

     

    

 

Exhibit A

Warrant Agreement

 

    A-1

     

    

 

Exhibit B

Registration Rights
Agreement

 

    B-1Exhibit 10.4

 

FOLEY TRASIMENE ACQUISITION CORP.

1701 Village Center Circle

Las Vegas, NV 89134

May 22, 2020

 

Cannae Holdings, Inc.

1701 Village Center Circle

Las Vegas, NV 89134

 

Ladies and Gentlemen:

 

This letter will confirm our agreement that,
commencing on the effective date (the “Effective Date”) of the registration statement (the “Registration
Statement”) for the initial public offering (the “IPO”) of the securities of Foley Trasimene
Acquisition Corp. (the “Company”) and continuing until the earlier of (i) the completion by the Company
of an initial business combination or (ii) the Company’s liquidation (in each case as described in the Registration Statement)
(such earlier date hereinafter referred to as the “Termination Date”), Cannae Holdings, Inc. (“Cannae
Holdings”) shall take steps directly or indirectly to make available to the Company certain office space, secretarial
and administrative services as may be required by the Company from time to time, situated at 1701 Village Center Circle, Las Vegas,
NV 89134 (or any successor location). In exchange therefore, the Company shall pay Cannae Holdings a sum of $5,000 per month, respectively,
on the Effective Date and continuing monthly thereafter until the Termination Date. Cannae Holdings hereby agrees that it does
not have any right, title, interest or claim of any kind in or to any monies that may be set aside in a trust account (the “Trust
Account”) that may be established upon the consummation of the IPO (the “Claim”) and hereby
waives any Claim it may have in the future as a result of, or arising out of, any negotiations, contracts or agreements with the
Company and will not seek recourse against the Trust Account for any reason whatsoever.

 

	 	Very truly yours,
	 	 
	 	FOLEY TRASIMENE ACQUISITION CORP.
	 	 
	 	By:	/s/ Michael L. Gravelle
	 	Name:	Michael L. Gravelle
	 	Title:	General Counsel and Corporate Secretary

 

AGREED TO AND ACCEPTED BY:

 

	CANNAE HOLDINGS, INC.
	 
	By:	/s/ Richard L. Cox	 
	Name:	Richard L. Cox
	Title:	Chief Financial Officer

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00309-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00309-of-00352.parquet"}]]